Biopsy Guidance System Market size is expected to reach USD 1,383.5 million by 2028
Biopsy Guidance System Industry Overview The global biopsy guidance system market size was valued at USD 934.4 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. The demand for biopsy guidance systems is rapidly growing, owing to an upsurge in the prevalence of cancer cases across the globe, a surge in the geriatric population, an increasing preference for non-invasive procedures, technological advancements, and increasing government initiatives. The COVID-19 pandemic has resulted in significant reductions in cancer screening, cancer management visits, and cancer procedures across the globe. The repercussions of delayed cancer detection owing to COVID-19 were investigated in a study undertaken in the U.K. and published in The Lancet Oncology in March 2021. The study covered data from over 100,000 people with breast, colorectal, esophageal, or lung cancer. The study found that 1 and 5-year cancer survival ra...